IFCC eNews: September 2021 |
 |
| Full PDF version |
IN THIS ISSUE:
The AFCB, AFCC EFLM Townhall is a unique opportunity to bring everyone together in these regions and allow for exchange of ideas and free communication between various organizations.
September 15th, 2021
09.00 am -12.00 pm Central Europe time zone
(Rome, Cape Town)
Members of AFCB, AFCC and EFLM Regional Federations and National Societies interested in participating in this open communication forum to significantly enhance communication within our laboratory medicine community had the possibility to attend and could ask question in the Discussion Forum via chat.
Format: brief presentations by IFCC EB together with Executive Boards of AFCB, AFCC, EFLM Regional Federations followed by a Discussion Forum.
gave brief presentations to update the membership on current and upcoming IFCC programmes and new initiatives globally or in specific regions.
Don't miss this opportunity!
Two other Townhalls are planned in October for the Americas (NAFCC and COLABIOCLI) as well as Asia-Pacific (APFCB), in their own time zones.
]]>
The IFCC webinar on "Evidence-based Laboratory Medicine" was held on 8 September 2021.
It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.
Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.
In this webinar, the speakers covered the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then they discussed how guidelines are implemented using the best available evidence. And finally, they looked at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.
Chair: Prof. Annalise Zemlin (South Africa)
The recorded webinar is available here
Certificate of Participation: available for all registrants
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital
]]>
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Authors will be notified of acceptance or rejection before 1st October 2021.
The presenting author of each abstract must register for the congress with “Full Registration”.
Abstracts are welcome in all fields of clinical chemistry, hematology, clinical molecular biology, and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the online abstract submission form.
]]>
Dear Colleagues,
The next IFCC webinar "Evidence-based Laboratory Medicine" will be held on 8 September 2021.
It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.
Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.
In this webinar, we will cover the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then we will discuss how guidelines are implemented using the best available evidence. And finally, we will look at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.
Chair: Prof. Annelise Zemlin (South Africa)
Please feel free to share this event on your social media with #IFCCwebinar
Recorded webinar: available on demand
Certificate of Participation: available for all registrants
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital
]]>
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Authors will be notified of acceptance or rejection before 1st October 2021.
The presenting author of each abstract must register for the congress with “Full Registration”.
Abstracts are welcome in all fields of clinical chemistry, hematology, clinical molecular biology, and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the online abstract submission form.
]]>
Dear Colleagues,
The next IFCC webinar "Metrology and Clinical Laboratory" will be held on 31 Aug, 2021.
Metrology is the science of measurements and their applications. It deals with the measurements, systems of units and instruments used to make them. Based on the data obtained from the measurements, decisions are taken. That is why it is very important that these data are reliable, reproducible and comparable between laboratories. The aim of metrology is to define and materialize the units of measurement and establish the traceability chain.
Recorded webinar: available on demand
Certificate of Participation: available for all registrants
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital
]]>
The 4th Industrial revolution brought many innovations to the industry and business world and introduced new technologies to laboratories. Although automation and data analysis are familiar to clinical laboratories, it’s the reality that laboratories will face new challenges due to increasing innovative techniques and big data.
In this panel, the advantages & benefits, and risks of Laboratory 4.0 were discussed from the perspective of laboratory professionals, universities, and industry. This webinar contributed to understanding the impact of Industry 4.0 on clinical laboratory processes, the effect of innovative technical developments on laboratory-industry cooperation, and laboratory-patient-physician communication. During the webinar, the future-oriented training of lab professionals for lab 4.0 was discussed.
click here for the on demand content
Certificate of Participation: available for all registrants
The "Code of Ethics of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)" is authored by the IFCC Taskforce on Ethics and it has been Reviewed & Approved by the IFCC Executive Board.
]]>Never respond to requests for personal information via email. Legitimate organizations will never ask for passwords, credit card numbers, or other personal information in an email. If you receive an email requesting this kind of information, DO NOT RESPOND, DO NOT REPLY, DO NOT CLICK ON LINKS OR IMAGES, and DO NOT OPEN ANY ATTACHMENTS with the message. If you think the email is legitimate, contact the company through their official contacts to confirm. Updating your systems with good security software can help defend data, users, systems, and companies from a wide range of risks.
Remember that the IFCC never requests money or credit card numbers, passwords, account information, or other personal information.
]]>